Cited by

• High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.

  Loarce-Martos J, García-Fernández A, López-Gutiérrez F, García-García V, Calvo-Sanz L, Del Bosque-Granero I, Terán-Tinedo MA, Boteanu A, Bachiller-Corral J, Vázquez-Díaz M. Loarce-Martos J, et al. Rheumatol Int. 2020 Dec;40(12):2015-2021. doi: 10.1007/s00296-020-04699-x. Epub 2020 Sep 18. Rheumatol Int. 2020. PMID: 32945944 Free PMC article.
• [Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination].

  Specker C, Aries P, Braun J, Burmester G, Fischer-Betz R, Hasseli R, Holle J, Hoyer BF, Iking-Konert C, Krause A, Krüger K, Krusche M, Leipe J, Lorenz HM, Moosig F, Schmale-Grede R, Schneider M, Strangfeld A, Voll R, Voormann A, Wagner U, Schulze-Koops H. Specker C, et al. Z Rheumatol. 2021 Aug;80(6):570-587. doi: 10.1007/s00393-021-01056-6. Z Rheumatol. 2021. PMID: 34309739 Free PMC article. Review. German. No abstract available.
• Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient.

  Abualfadl E, Ismail F, Shereef RRE, Hassan E, Tharwat S, Mohamed EF, Abda EA, Radwan AR, Fawzy RM, Moshrif AH, Noor RA, Senara S, Elazim MIA, Abaza NM, Raafat HA, El-Gazzar II, El-Hammady DH, Hammam N, Gheita TA, El-Mallah R; ECR COVID19-Study Group. Abualfadl E, et al. Rheumatol Int. 2021 Feb;41(2):345-353. doi: 10.1007/s00296-020-04736-9. Epub 2020 Nov 1. Rheumatol Int. 2021. PMID: 33130920 Free PMC article.
• COVID-19 vaccination in individuals with inflammatory rheumatic diseases.

  Skapenko A, Schulze-Koops H. Skapenko A, et al. Nat Rev Rheumatol. 2023 Feb;19(2):76-77. doi: 10.1038/s41584-022-00892-3. Nat Rev Rheumatol. 2023. PMID: 36517627 Free PMC article.
• Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative.

  Andersen KM, Bates BA, Rashidi ES, Olex AL, Mannon RB, Patel RC, Singh J, Sun J, Auwaerter PG, Ng DK, Segal JB, Garibaldi BT, Mehta HB, Alexander GC; National COVID Cohort Collaborative Consortium. Andersen KM, et al. Lancet Rheumatol. 2022 Jan;4(1):e33-e41. doi: 10.1016/S2665-9913(21)00325-8. Epub 2021 Nov 15. Lancet Rheumatol. 2022. PMID: 34806036 Free PMC article.